Related Experiment Video
Updated: Jun 10, 2026
12:27
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
Oligopeptide delivery carrier for osteoclast precursors
Bo Chi1, So Jeong Park, Min Hee Park
1Department of Chemistry and Nano Science and Division of Life and Pharmaceutical Sciences, Department of Bioinspired Science, Ewha Womans University, Seoul, Korea.
Bioconjugate Chemistry
|August 19, 2010
Summary
Modified nanoparticles efficiently deliver peptide drugs into bone marrow macrophages. Guanidinium-modified nanoparticles show superior uptake with no observed cytotoxicity, indicating potential for targeted drug delivery.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cell Biology
Background:
- Osteoclast precursor cells, or bone marrow macrophages (BMMs), are crucial targets for therapeutic interventions.
- Effective delivery of peptide drugs to these cells remains a challenge.
- Nanoparticle-based drug delivery systems offer a promising solution.
Purpose of the Study:
- To investigate the cellular uptake of peptide drugs delivered via modified nanoparticles into BMMs.
- To compare the efficacy of amine- versus guanidinium group-modified nanoparticles for drug delivery.
- To assess the cytotoxicity of these nanoparticle systems.
Main Methods:
- Encapsulation of a model peptide drug into dendritic amine and guanidinium group-modified nanoparticles using a solvent-dropping method.
- Analysis of cellular uptake using flow cytometry and spectrofluorimetry.
- Evaluation of cell viability using standard cytotoxicity assays.
Main Results:
- The model peptide drug alone was not effectively taken up by BMMs.
- Nanoparticle systems demonstrated significant cellular uptake.
- Guanidinium group-modified nanoparticles exhibited more efficient uptake compared to amine group-modified nanoparticles.
- Both nanoparticle types showed no significant cytotoxicity at concentrations up to 100 microg/mL.
Conclusions:
- Dendritic amine and guanidinium group-modified nanoparticles are effective carriers for delivering peptide drugs to BMMs.
- Guanidinium modification enhances nanoparticle uptake by BMMs.
- These nanoparticles represent a safe and efficient platform for targeted drug delivery to osteoclast precursors.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:30Bone Cells and Tissue
Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
01:38Receptor-mediated Endocytosis
Overview
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...